Physician

Paul A.s. Fishkin, MD

According to 2025 Medicare claims, Paul Fishkin, MD (NPI: 1063411379) practices hematology/oncology in the Peoria, IL market, with the plurality of this provider's patient population coming from Tazewell, IL. This provider's primary affiliated billing organization is ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C (NPI: 1801896063; TIN: 371331017) and primary practice location at 61520-2444. Fishkin is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Fishkin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,276 traditional Medicare patients, billed 238,901 HCPCS/CPT codes, and received $3,167,037 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,988 prescription claims across 406 beneficiaries totaling $6,605,465 in drug costs, led by Revlimid (Lenalidomide). DME data shows 52 claims. Open Payments data shows 4 records totaling $62,544. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,576,616 to $6,605,465. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $14,752 to $2,316.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,347	219,974	$2,633,039
2016	1,462	248,204	$2,918,894
2017	1,588	332,786	$3,953,565
2018	1,706	321,186	$4,233,046
2019	1,715	350,693	$4,993,231
2020	1,485	277,016	$4,900,692
2021	1,425	262,998	$4,803,997
2022	1,210	222,876	$3,429,646
2023	1,287	264,767	$3,817,737
2024	1,276	238,901	$3,167,037

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	249	2,259	$1,576,616
2016	252	2,469	$2,464,135
2017	256	2,515	$2,289,968
2018	308	2,633	$2,606,470
2019	291	2,752	$3,226,038
2020	304	2,304	$3,371,716
2021	314	2,317	$5,099,736
2022	330	2,778	$5,984,686
2023	390	2,883	$5,038,703
2024	406	2,988	$6,605,465

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	334	$50,960
2016	12	182	$34,751
2017	N/R	57	$10,434
2018	N/R	115	$9,921
2019	N/R	116	$11,121
2020	N/R	56	$3,184
2021	N/R	41	$2,193
2022	N/R	76	$5,259
2023	N/R	13	$79
2024	N/R	52	$2,316

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	313	583	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	291	332	$62
80053	Blood test, comprehensive group of blood chemicals	378	963	$10
36415	Insertion of needle into vein for collection of blood sample	547	1,554	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	511	1,509	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	77	2,156	$1,266,782
Cabometyx	Cabozantinib S-Malate	35	1,050	$910,790
Lenalidomide	Lenalidomide	54	1,421	$719,718
Imbruvica	Ibrutinib	39	1,232	$530,736
Tagrisso	Osimertinib Mesylate	23	690	$390,382

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	26	$1,899
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	26	$417

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$62,544	BeiGene, Ltd.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul A.s. Fishkin, MD?

Tedicare shows public-source Medicare data for Paul A.s. Fishkin, MD (NPI 1063411379), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul A.s. Fishkin, MD have ACO affiliation data?

Paul A.s. Fishkin, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Paul A.s. Fishkin, MD?

Paul A.s. Fishkin, MD is linked to ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C (billing NPI 1801896063) in the available physician profile data.

Does Paul A.s. Fishkin, MD have Open Payments data?

Paul A.s. Fishkin, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.